Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT07414212 · RECRUITING
Trial details
- NCT number
- NCT07414212
- Sponsor
- Biogipuzkoa Health Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2026-11-25
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.